| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | SK1LVT23A1 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Repulsive guidance molecule A inhibitor |
| Primary Target | |
|---|---|
| repulsive guidance molecule BMP co-receptor a |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Spinal Cord Injuries | 2 | D013119 | ClinicalTrials |
| Multiple Sclerosis | 2 | D009103 | ClinicalTrials |
| Stroke | 2 | D020521 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1791416-49-3 |
| ChEMBL | CHEMBL4297743 |
| FDA SRS | SK1LVT23A1 |
| Guide to Pharmacology | 9290 |
CONTENTS